6-K

REPORT OF FOREIGN PRIVATE ISSUER

Company: Clearmind Medicine Inc.
Filed: January 10, 2024
Period of Report: January 10, 2024
Accession Number: 0001213900-24-002690

View Document ↗ View on SEC.gov ↗